Clinical and Health Economic Impact of Robot-assisted Surgery vs Conventional Laparoscopy : the Case of Gastric Bypass

December 9, 2015 updated by: IHU Strasbourg

Prospective, Single-blind, Randomized, Non-inferiority, and Controlled Study of Clinical and Health Economic Impact of Robot-assisted Surgery Versus Conventional Laparoscopy in Bariatric Surgery: the Case of Gastric Bypass

The purpose of this study is to gather clinical and economic evidence on the use of robotics for bariatric surgery (gastric bypass).

This monocentric, randomized, single blind, controlled study will evaluate post-operative pain, quality of life and appetite, post-operative complication incidence. It will also provide information on direct and indirect costs of surgery.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Robot-assisted Surgery Versus Conventional Laparoscopy in Bariatric Surgery (Gastric Bypass): a prospective, single-blind, randomized, non-inferiority, and controlled study The main evaluation criterion is 24h post-operative pain assessed using visual analog scale (VAS). Secondary criteria included for clinical assessment: post 24h pain, excess weight loss, quality of life, appetite, complications, conversion rate; and for health-economics assessment : duration of surgical steps, length of stay, return to normal activity and their conversion to cost, consumables, estimation of indirect costs and benefits (e.g., robotics perception, publication).

In this study, main inclusion criteria include major obesity (IMC ≥ 35) with co-morbidities or morbid obesity (IMC ≥ 40), scheduled gastric bypass surgery Main contraindications are previous bariatric surgery and previous major abdominal surgeries To test robotic-assisted surgery non-inferiority on VAS pain score 24h post-surgery, a total of 128 patients (64 per arm) is to be included (alpha 2,5%; power 90%; drop-out rate: 5%).

The study will include 12 months of follow-up post-surgery for each patient. The total study duration is 2 years and 3 months.

Study Type

Interventional

Enrollment (Anticipated)

118

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Strasbourg, France, 67 000
        • Service de Chirurgie Digestive et Endocrinienne

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patient presenting with major obesity (BMI ≥ 35) with co-morbidities or morbid obesity (BMI ≥ 40)according to French HAS (Haute Autorité de Santé) and CNAMTS (Caisse nationale de l'assurance maladie des travailleurs salariés)criteria for whom gastric bypass is scheduled
  • Male or female between 18 and 65 years old
  • Patient registered with the French Social Security
  • Patient having provided a written informed consent prior to enrolment
  • Patient accepting to attend follow-up visits as required by study protocol

Exclusion Criteria:

  • Patient with a BMI ≥ 60
  • Patient with a contraindication for laparoscopic gastric bypass with or without robotic assistance
  • Patient having had prior bariatric surgery
  • Patient having had prior major abdominal surgery
  • Patient in exclusion period of another clinical study
  • Patient pregnant or breastfeeding
  • Patient without sufficient knowledge of french language or unable to receive or understand study related information and answer to questionnaires
  • Patient with no or limited legal capacity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Robot-assisted surgery
Robot-assisted (da Vinci surgical system) gastric bypass
Gastric bypass
Active Comparator: Conventional laparoscopy
Laparoscopic gastric bypass
Gastric bypass

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
24h postoperative pain
Time Frame: 24h
Pain assessment 24h post surgery (visual analog scale)
24h

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of post-operative pain
Time Frame: 24h, 8 days, 1, 3, 6 and 12 months
Evaluation of post-operative pain (beyond 24h post-operative) using VAS
24h, 8 days, 1, 3, 6 and 12 months
Evaluation of quality of life (BAROS and GIQLI)
Time Frame: At 1, 3, 6 and 12 months
Evaluation of quality of life using BAROS and GIQLI questionaires
At 1, 3, 6 and 12 months
Evaluation of appetite level
Time Frame: At 8 days, 1, 3, 6 and 12 months
Evaluation of appetite level using VAS
At 8 days, 1, 3, 6 and 12 months
Percentage of excess weight loss
Time Frame: At 8 days, 1, 3, 6 and 12 months
Measure of excess weight loss - % from baseline
At 8 days, 1, 3, 6 and 12 months
Conversion rate to conventional laparoscopy
Time Frame: During the procedure (Day 0)
Conversion rate to conventional laparoscopy (only applicable to robot-assisted surgery arm)
During the procedure (Day 0)
Nature of per-operative complications
Time Frame: During the procedure (Day 0)
Nature of per-operative complications
During the procedure (Day 0)
Nature of post-operative complications
Time Frame: Following the procedure (Day 0) up to 12 months
Nature of post-operative complications
Following the procedure (Day 0) up to 12 months
Evaluation of operative times
Time Frame: During the procedure (Day 0)
Evaluation of key steps of gastric bypass surgery, OR occupation time
During the procedure (Day 0)
Evaluation of direct costs
Time Frame: During the procedure (day 0) and up to 12 months
Direct costs include material used, OR occupation time, length of stay, return to normal activity
During the procedure (day 0) and up to 12 months
Evaluation of indirect costs
Time Frame: Up to 12 months
Combination of number of patients having surgery, perception of robot-assisted surgery by both personnel and patients, publications, and communications
Up to 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Michel Vix, Service de Chirurgie Générale et Endocrinienne - Nouvel Hôpital Civil - Strasbourg

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2012

Primary Completion (Actual)

June 1, 2015

Study Completion (Actual)

June 1, 2015

Study Registration Dates

First Submitted

December 10, 2012

First Submitted That Met QC Criteria

January 2, 2013

First Posted (Estimate)

January 4, 2013

Study Record Updates

Last Update Posted (Estimate)

December 10, 2015

Last Update Submitted That Met QC Criteria

December 9, 2015

Last Verified

May 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Morbid Obesity

Clinical Trials on Gastric bypass

3
Subscribe